The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 23, 2019
Filed:
Jan. 26, 2018
Applicant:
A1m Pharma Ab, Lund, SE;
Inventors:
Stefan Hansson, Lomma, SE;
Bo Åkerström, Lund, SE;
Assignee:
A1M PHARMA AB, Lund, SE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); G01N 33/00 (2006.01); G01N 33/68 (2006.01); G01N 33/72 (2006.01); A61K 38/17 (2006.01); A61K 38/38 (2006.01); A61K 38/40 (2006.01); A61K 38/42 (2006.01); A61K 38/44 (2006.01);
U.S. Cl.
CPC ...
G01N 33/00 (2013.01); A61K 38/1709 (2013.01); A61K 38/1774 (2013.01); A61K 38/38 (2013.01); A61K 38/40 (2013.01); A61K 38/42 (2013.01); A61K 38/44 (2013.01); C12Y 114/99003 (2013.01); G01N 33/689 (2013.01); G01N 33/721 (2013.01); G01N 2800/368 (2013.01);
Abstract
Disclosed are biomarkers for preeclampsia including elevated levels of free hemoglobin, including free fetal haemoglobin and the ratio of free fetal hemoglobin to total free hemoglobin. Also disclosed are methods of treating preeclampsia using a therapeutic agent that reduces free circulating hemoglobin levels.